Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development

ABSTRACT Colorectal cancer (CRC) is the third most common malignancy and the fourth most common cause of cancer related death worldwide. This study was designed to find tumor suppressors involved in CRC development by performing RNA-seq. Eight CRC cell lines and 130 cases of primary CRC samples were used. RNA-seq, methylation-specific PCR (MSP), flow cytometry, transwell assays, and a xenograft mouse model were used. Reduction of TMEM176A expression was confirmed in human CRC cells by RNA-seq. TMEM176A was expressed in LS180 and SW620 cells, loss of TMEM176A expression was observed in LOVO, HCT116, RKO, and DLD1 cells, and reduced TMEM176A expression was found in HT29 and SW480 cells. Unmethylation of the TMEM176A promoter was found in LS180 and SW620 cells, whereas complete methylation was found in LOVO, HCT116, RKO, and DLD1 cells, and partial methylation was found in HT29 and SW480 cells. Promoter region methylation correlated with loss of/reduced expression of TMEM176A. Re-expression of TMEM176A was induced by 5-aza-2′-deoxycytidine. TMEM176A was methylated in 50.77% of primary colorectal cancers. Methylation of TMEM176A was associated with tumor metastasis (P<0.05) and was an independent prognostic factor for 5-year overall survival (OS) according to Cox proportional hazards model analysis (P<0.05). TMEM176A induced apoptosis and inhibited cell migration and invasion in CRC cells. TMEM176A suppressed CRC cell growth both in vitro and in vivo. Our results suggest that expression of TMEM176A is regulated by promoter region methylation. TMEM176A methylation is an independent prognostic marker for 5-year OS in CRC, and may act as a tumor suppressor in CRC.

[1]  H. Fehling,et al.  RORγt+ cells selectively express redundant cation channels linked to the Golgi apparatus , 2016, Scientific Reports.

[2]  J. Herman,et al.  SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma , 2010, Epigenetics.

[3]  J. Herman,et al.  Accumulation of Promoter Methylation Suggests Epigenetic Progression in Squamous Cell Carcinoma of the Esophagus , 2006, Clinical Cancer Research.

[4]  V. Palička,et al.  Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients. , 2013, Folia biologica.

[5]  S. Davis,et al.  RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma , 2016, Oncogene.

[6]  C. Wilson,et al.  Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation , 2000, Nature Cell Biology.

[7]  L. Tesson,et al.  Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts. , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  L. Zhao,et al.  Microarray Comparative Genomic Hybridization Reveals Genome-Wide Patterns of DNA Gains and Losses in Post-Chernobyl Thyroid Cancer , 2006, Radiation research.

[9]  R. Wolff,et al.  Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. , 2005, Cancer research.

[10]  D. Demetrick,et al.  Expression of MS4A and TMEM176 Genes in Human B Lymphocytes , 2013, Front. Immunol..

[11]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[12]  J. Herman,et al.  Promoter methylation of HIN-1 in the progression to esophageal squamous cancer , 2008, Epigenetics.

[13]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[14]  Adam Santaniello,et al.  Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. , 2013, Human molecular genetics.

[15]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[16]  Kenneth K Wang,et al.  Allelic imbalance of 7q32.3-q36.1 during tumorigenesis in Barrett's esophagus. , 2002, Cancer research.

[17]  J. Herman,et al.  Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer , 2013, Epigenetics.

[18]  Quang Bui,et al.  Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology. , 2012, Acta histochemica.

[19]  C. Louvet,et al.  Generation of a Double KO Mouse by Simultaneous Targeting of the Neighboring Genes Tmem176a and Tmem176b Using CRISPR/Cas9: Key Steps from Design to Genotyping. , 2016, Journal of genetics and genomics = Yi chuan xue bao.

[20]  J. Herman,et al.  Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer , 2013, The Journal of pathology.

[21]  J. Herman,et al.  Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling , 2014, Journal of cellular and molecular medicine.

[22]  R. Grimer,et al.  Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma , 2013, Epigenetics.

[23]  Herman Waldmann,et al.  Tmem176B and Tmem176A are associated with the immature state of dendritic cells , 2010, Journal of leukocyte biology.

[24]  M. Loda,et al.  Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.

[25]  I. Chowers,et al.  Transcriptome Analysis on Monocytes from Patients with Neovascular Age-Related Macular Degeneration , 2016, Scientific Reports.